Virinchi Ltd Board Approves Rs 56 Crore Fundraising Through Convertible Warrants

1 min read     Updated on 15 Oct 2025, 07:20 PM
scanx
Reviewed by
Naman SharmaScanX News Team
Overview

Virinchi Ltd's Board has approved raising up to Rs 56 crore through a preferential issue of 2 crore convertible equity warrants at Rs 28 per warrant. 80% of the warrants will be allotted to promoter group Vivo Bio Tech Limited, and 20% to public entity IT Peer Technologies LLC. Post-conversion, promoter shareholding is expected to increase from 37.51% to 44.44%. The warrants are convertible within 18 months of allotment, subject to shareholder approval at an EGM on November 15, 2025.

22081863

*this image is generated using AI for illustrative purposes only.

Virinchi Ltd , a leading technology solutions provider, has announced a significant move to bolster its financial position. The company's Board of Directors has approved a fundraising initiative through the preferential issue of convertible equity warrants, aiming to raise up to Rs 56.00 crore.

Key Details of the Fundraising

  • Total Warrants: 2 crore convertible equity warrants
  • Issue Price: Rs 28.00 per warrant
  • Total Fundraising: Up to Rs 56.00 crore

Allocation of Warrants

Allottee Category Number of Warrants Percentage
Vivo Bio Tech Limited Promoter Group 1,60,00,000 80.00%
IT Peer Technologies LLC Public 40,00,000 20.00%

Impact on Shareholding Structure

The conversion of these warrants is expected to significantly alter the company's shareholding pattern:

Category Pre-Issue Post-Issue
Promoters and Promoter Group 37.51% 44.44%
Public 62.49% 55.56%

Key Points

  1. Conversion Timeline: The warrants are convertible into equity shares within 18 months from the date of allotment.
  2. Pricing: The issue price of Rs 28.00 per warrant is higher than the floor price determined as per SEBI regulations.
  3. Approval Process: The fundraising plan is subject to shareholder approval at an upcoming Extraordinary General Meeting (EGM) scheduled for November 15, 2025.
  4. Additional Board Decisions:
    • Approved revision in remuneration for Chairman Emeritus Mr. Viswanath Kompella.
    • Set the cut-off date as November 8, 2025, for determining shareholder eligibility to vote at the EGM.

Implications

This strategic move by Virinchi appears aimed at strengthening its financial position and potentially funding future growth initiatives. The significant increase in promoter shareholding post-conversion could indicate strong promoter confidence in the company's future prospects.

Investors and stakeholders should note that this development may impact the company's capital structure and ownership dynamics. As always, it's advisable to consider these corporate actions in the context of the company's overall financial health and growth strategy.

Historical Stock Returns for Virinchi

1 Day5 Days1 Month6 Months1 Year5 Years
+0.46%+4.40%-9.64%+31.21%-10.81%-22.18%
like16
dislike

Virinchi Limited to Discuss SaaS Business Restructuring and Expansion Plans in Upcoming Board Meeting

1 min read     Updated on 18 Aug 2025, 05:33 PM
scanx
Reviewed by
Shriram ShekharScanX News Team
Overview

Virinchi Limited has scheduled a board meeting for August 22, 2025, to discuss strategic business restructuring. Key agenda items include restructuring the SaaS business into a wholly-owned subsidiary through a slump sale and exploring partial divestment options. The company aims to reduce debt, expand its healthcare vertical, and achieve focused growth. These moves could potentially impact the company's future direction and shareholder value.

17064221

*this image is generated using AI for illustrative purposes only.

Virinchi Limited has announced a crucial board meeting scheduled for August 22, 2025, to deliberate on strategic business restructuring plans that could significantly impact the company's future direction.

Key Agenda Items

The board meeting, set to take place at the company's registered office, will focus on two major strategic initiatives:

  1. SaaS Business Restructuring: The company is considering restructuring its Software as a Service (SaaS) business into a wholly-owned subsidiary through a slump sale. This move is aimed at creating a focused SaaS entity and potentially unlocking long-term shareholder value.

  2. Partial Divestment and Fund Allocation: Virinchi is exploring options to divest a portion of its SaaS business. The company is considering various avenues for this divestment, including private investment, strategic partnerships, or an Initial Public Offering (IPO).

Strategic Objectives

The proposed restructuring and divestment plans are designed to achieve multiple strategic objectives:

  1. Debt Reduction: Proceeds from the potential divestment of the SaaS business are intended to be used for reducing debt at the consolidated level, which could improve the company's financial health.

  2. Healthcare Expansion: Part of the funds raised through the divestment is planned to be invested in the oncology healthcare vertical. This investment aims to support the expansion of the Virinchi hospital chain, potentially strengthening the company's presence in the healthcare sector.

  3. Focused Growth: By creating a separate entity for the SaaS business, Virinchi Limited appears to be positioning itself for more focused growth and potentially enhanced operational efficiency in both its technology and healthcare verticals.

Investor Implications

These strategic moves, if approved and implemented, could have significant implications for Virinchi's shareholders:

  • The creation of a focused SaaS subsidiary might lead to better valuation and visibility for this business segment.
  • Debt reduction could improve the company's financial ratios and potentially its market perception.
  • Expansion in the healthcare sector might diversify revenue streams and create new growth opportunities.

Investors and market watchers will be keenly awaiting the outcomes of this board meeting, as the decisions made could shape Virinchi Limited's business structure and growth trajectory in the coming years.

The company has duly informed the stock exchanges about this upcoming board meeting, in compliance with regulatory requirements.

Note: This article is based on the company's official communication to stock exchanges. Investors are advised to consult financial experts before making any investment decisions.

Historical Stock Returns for Virinchi

1 Day5 Days1 Month6 Months1 Year5 Years
+0.46%+4.40%-9.64%+31.21%-10.81%-22.18%
like16
dislike
More News on Virinchi
Explore Other Articles
28.21
+0.13
(+0.46%)